ACG Pharmapack targets Rs 250 crore turnover by FY13
Backed by innovative value-added products and renewed exports focus, ACG Pharmapack aiming at exciting times.
Mumbai, September 24, 2012: ACG Pharmapack, a part of ACG Worldwide is targeting a turnover of Rs 250 crore by the end of FY13. It is worth noting here that the company aims to achieve this turnover by expanding its portfolio with innovative value-added products and at the same time, strengthening its base in the export markets.
"We expect to achieve a turnover to Rs 250 crore in FY13 from Rs 200 crore in FY12. The growth will be owing to value-added products like Alukbliss and Brandshield and expand our export markets. The company has projected a turnover of Rs 500 crore in FY15," Hemant Mhatre, Head - Sales and Marketing, ACG Pharmapack.
It may be noted here that the company has a facility near Pune in Maharashtra that has a total capacity of 15,000 MT per annum.
"We have introduced innovative Alukbliss and Brandshield, innovative and effective solutions for one of the major challenges faced by the pharma industry- counterfeit drugs.
Suitable for stable formulations without the need for high barrier protection, Alukbliss is ideal for companies looking to differentiate their products with a distinct identity and aesthetically eye-catching packaging, said Mhatre.
The company supplies its packaging products to the leading pharma companies in the country and exports to over 70 countries across the globe.